ClinicalTrials.gg
RecruitingNCT06284057LSCBRUpdated Mar 6, 2024

Lower Silesia Culotte Bifurcation Registry (LSCBR).

An observational study in Safety Issues and Efficacy, Self, sponsored by Regional Cardiology Center, The Copper Health Centre (MCZ),. Recruiting at 2 sites in Poland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-03-06.

Sponsored by Regional Cardiology Center, The Copper Health Centre (MCZ), · Observational

How we know

From the registry’s dates

  • Started Apr 2013; still recruiting 13 years 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
400
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 62 studies in Acute Coronary Syndrome with a site in Poland — 12 open to participants now, 16 under way, 2 of them phase 3. Acute Coronary Syndrome · Poland.

Planned enrollment
9th of 13
400 · median 1,200
Started
2013
with 1 other
Observational
13 of 62
3 open now
Primary completion
2028-04
later than 12 of 15 live
Registered
56th of 62
by date

Among the 62 studies in Acute Coronary Syndrome with a site in Poland, this one is the 9th largest by planned enrollment of the 13 observational ones that give a count, is one of 2 that started in 2013, is one of 13 observational ones, reaches primary completion later than 12 of the 15 other live ones, and was the 56th registered.

Acute Coronary Syndrome

1,491 studies on the registry are indexed under Acute Coronary Syndrome; 272 are open to participants now.

Browse Acute Coronary Syndrome studies →

Open to participants now

12 of the 62 studies in Acute Coronary Syndrome with a site in Poland are open now. Recruiting first, the newest first:

6 more — sign in →

All 12 open studies →

A study can be open while its sites in Poland have not opened yet or have stopped. Only those recruiting at a site in Poland →

Who these studies take

Of the 195 Acute Coronary Syndrome studies recruiting now, 144 (74%) set no upper age limit and 19 (10%) stop at 75 or younger; 15 take children under 18; 15 take healthy volunteers.

This study: 18 Years and older · all sexes.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 62 studies in Acute Coronary Syndrome with a site in Poland, or all of them as a file.
02

Study summary

The study aimed to evaluate the outcomes of bifurcation PCI using two techniques (Culotte vs. DK-Culotte) using data from a retrospective analysis.

Read the detailed description

The study contains a retrospective analysis of subjects who have undergone PCI in two high-volume cooperative Cardiac Departments in the Lower Silesia Region (Poland) between April 2012 and January 2024. Data regarding all performed PCI from these periods were prescreened in terms of bifurcation lesion with subsequent implantation of two stents using the Culotte technique or the DK-Culotte technique. The indication for percutaneous coronary intervention (PCI) was based either on a judgment made by the Heart Team or on a particular clinical indication (ongoing ischemia, lack of will for the alternative treatment options, presence of significant angiographic CAD suitable for PCI due to ESC/ESH recommendation). The decision to perform the two-stent technique PCI was left to the operator's dissertation based on clinical and angiographical features. All patients were thoroughly informed about all therapeutic options and PCI-related risks before providing written informed consent for the procedure. There were no clinical or vessel-related exclusion criteria (lesion anatomy, length, tortuosity, severity). However, patients who had undergone PCI with coronary stents prior to the index procedure with respect to the bifurcation lesion studied were excluded from the study.

03

Conditions studied

  • Safety Issues
  • Efficacy, Self

Keywords

  • Percutaneous coronary intervention (PCI)
  • Bifurcation lesion
  • Culotte Technique
  • Double Kiss Culotte Technique
  • Acute Coronary Syndrome
  • Two-Stent Technique
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

The study includes a retrospective analysis of subjects who underwent PCI in two cooperative cardiac centers in the Lower Silesia region between April 2012 and January 2024. Data from the participating centers on all PCIs performed during these periods were prescreened for bifurcation lesions with subsequent implantation of two stents using the Culotte technique or the DK-Culotte technique. The indication for percutaneous coronary intervention (PCI) was based on the judgment of the cardiac team or on a specific clinical indication (persistent ischemia, unwillingness to accept alternative treatment options, presence of significant angiographic CAD suitable for PCI). The decision to perform PCI with the two-stent technique was left to the operator's judgment based on clinical and angiographic characteristics.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Presence of significant changes in the coronary bifurcation requiring the implantation of two coronary stents using the Culotte or DK Culotte technique.

Exclusion criteria

Exclusion Criteria:

  • Patients who underwent PCI with coronary stents prior to the index procedure for the bifurcation lesion studied.
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
400 participants (estimated)
Patient registry
No

Groups and cohorts

  • Culotte Group

    Data regarding patient with performed PCI- bifurcation with subsequent implantation of two stents using the Culotte technique

    Procedure: Bifurcation PCI with two stent technique Culotte Technique or Double Kiss (DK) Culotte

  • Double Kiss (DK) Culotte Group

    Data regarding patient with performed PCI- bifurcation with subsequent implantation of two stents using the Double Kiss- Culotte technique. DK-Culotte technique is a variety of classical "Culotte techniques" in which one additional kissing balloon dilation is performed just after SB stenting, and prior to MB stent implantation.

    Procedure: Bifurcation PCI with two stent technique Culotte Technique or Double Kiss (DK) Culotte

Interventions

  • ProcedureBifurcation PCI with two stent technique Culotte Technique or Double Kiss (DK) Culotte

    Patient with CAD and coexisting bifurcation lesion requiring two-stent approach treated with Culotte Technique or Double Kiss (DK) Culotte due to operator distraction.

06

What researchers measure

Primary outcomes

  1. Target lesion failure (TLF)

    The primary endpoint was target lesion failure (TLF): the composite of cardiac death, target vessel myocardial infarction (TVMI), or clinically driven TLR.

    Time frame: Final assessment - 5 years after the initial hospitalization; followed by evaluation every 6 months from the end of the hospitalization until the final assessment (5 years)

Secondary outcomes

  1. MACE

    The secondary composed outcome was MACE: myocardial infarction (MI), cardiac death, MB-TLR or/and SB-TLR

    Time frame: Final assessment - 5 years after the initial hospitalization; followed by evaluation every 6 months from the end of the hospitalization until the final assessment (5 years)

Other outcomes

  1. Stent thrombosis

    Stent thrombosis in a stent implanted in a bifurcation during primary intervention. Stent thrombosis was defined according to The Academic Research Consortium-2 consensus document. The presence of a thrombus† that originates in the stent/scaffold or in the segment 5 mm proximal or distal to the stent/scaffold or in a side branch originating from the stented/scaffolded segment and the presence of at least 1 of the following criteria: 1)Acute onset of ischemic symptoms at rest 2)New electrocardiographic changes suggestive of acute ischemia 3)Typical rise and fall in cardiac biomarkers (refer to definition of spontaneous myocardial infarction) or Pathological confirmation of stent/scaffold thrombosis

    Time frame: Final assessment - 5 years after the initial hospitalization; followed by evaluation every 6 months from the end of the hospitalization until the final assessment (5 years)

  2. Stent restenosis

    Stent restenosis in a stent placed in a bifurcation during primary intervention. Stent restenosis should be confirmed by either angiography or intravascular assessment.

    Time frame: Final assessment - 5 years after the initial hospitalization; followed by evaluation every 6 months from the end of the hospitalization until the final assessment (5 years)

07

Study locations

2 of 2 sites recruiting
  • Department of Cardiology, Provincial Specialized Hospital in Legnica,
    Legnica, Lower Silesia 59-220, Poland
    Recruiting
    • Mateusz Barycki, M.D · Contactmateusz.barycki@gmail.com · +48767211446
    • Piotr Rola, M.D. Ph.D · Contactpiotr.rola@gmail.com · +48767211446
    • Mateusz Barycki, MD · Principal investigator
    • Piotr Rola, MD PhD · Sub investigator
  • Department of Cardiology, The Copper Health Centre (MCZ)
    Lubin, Lower Silesia 59-300, Poland
    Recruiting
    • Adrian Włodarczak, Assoc Prof. · Contactwlodarczak.adrian@gmail.com · +48768460300
    • Szymon Włodarczak, MD · Contactwlodarczak.szy@gmail.com · +4876 846 03 00
    • Adrian Włodarczak, Assoc Prof. · Principal investigator
    • Szymon Włodarczak, MD · Sub investigator
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Apr 2013 (actual). Primary completion is estimated for Apr 2028, 180 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 21, 2024
First posted
Feb 28, 2024
StartActual
Apr 1, 2013
Primary completionEst.
Apr 1, 2028
CompletionEst.
Apr 1, 2028
Last update
Mar 6, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 6, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06284057
Lead sponsor
Regional Cardiology Center, The Copper Health Centre (MCZ),
Collaborators
Department of Cardiology, Provincial Specialized Hospital in Legnica, 59-200 Legnica, Poland.
Responsible party
Adrian Włodarczak (Professor, Regional Cardiology Center, The Copper Health Centre (MCZ),) — Principal investigator
First posted
Feb 28, 2024
Start date
Apr 1, 2013
Primary completion
Apr 1, 2028 (estimated)
Completion
Apr 1, 2028 (estimated)
Last update
Mar 6, 2024

Study contacts

Mateusz Barycki, MD
Contact
mateusz.barycki@gmail.com
+48767211446
Adrian Włodarczak, Assoc. Prof.
Contact
adrian.wlodarczak@gmail.com
+48768460300
Adrian Włodarczak, Assoc. Prof.
principal investigator · Regional Cardiology Center, The Copper Health Centre (MCZ),

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion